propofol has been researched along with Digestive System Disorders in 10 studies
Propofol: An intravenous anesthetic agent which has the advantage of a very rapid onset after infusion or bolus injection plus a very short recovery period of a couple of minutes. (From Smith and Reynard, Textbook of Pharmacology, 1992, 1st ed, p206). Propofol has been used as ANTICONVULSANTS and ANTIEMETICS.
propofol : A phenol resulting from the formal substitution of the hydrogen at the 2 position of 1,3-diisopropylbenzene by a hydroxy group.
Excerpt | Relevance | Reference |
---|---|---|
"Although obesity was associated with an increased frequency of SRCs, propofol sedation can be used safely in obese patients undergoing AEPs when administered by trained professionals." | 7.77 | Obesity as a risk factor for sedation-related complications during propofol-mediated sedation for advanced endoscopic procedures. ( Azar, R; Cote, GA; Early, D; Edmundowicz, SA; Hall, M; Hovis, CE; Hovis, RM; Jonnalagadda, SS; Kushnir, V; Mullady, DK; Murad, F; Waldbaum, L; Wani, S, 2011) |
"Although obesity was associated with an increased frequency of SRCs, propofol sedation can be used safely in obese patients undergoing AEPs when administered by trained professionals." | 3.77 | Obesity as a risk factor for sedation-related complications during propofol-mediated sedation for advanced endoscopic procedures. ( Azar, R; Cote, GA; Early, D; Edmundowicz, SA; Hall, M; Hovis, CE; Hovis, RM; Jonnalagadda, SS; Kushnir, V; Mullady, DK; Murad, F; Waldbaum, L; Wani, S, 2011) |
"Propofol was administered by bolus injection, with a standard protocol of 40 mg for patients <70 years old, 30 mg for patients 70-89 years old, and 20 mg for patients 90 years or older." | 2.74 | Low-dose propofol sedation for diagnostic esophagogastroduodenoscopy: results in 10,662 adults. ( Hidaka, N; Horiuchi, A; Ichise, Y; Kajiyama, M; Nakayama, Y; Tanaka, N, 2009) |
"Mean propofol dose was 301 mg (range 100-1000 mg)." | 1.32 | Endoscopist administered propofol for upper-GI EUS is safe and effective: a prospective study in 500 patients. ( Raymond, G; Sahai, AV; Yusoff, IF, 2004) |
"Propofol is a rapidly acting agent that produces an excellent hypnotic state, but its use is typically limited to anesthesiologist-assisted cases because of the inadequacy of current monitoring standards to reliably detect early stages of respiratory depression." | 1.31 | Gastroenterologist-administered propofol for therapeutic upper endoscopy with graphic assessment of respiratory activity: a case series. ( Conwell, DL; Dumot, JA; Morrow, JB; Shay, SS; Vargo, JJ; Zuccaro, G, 2000) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 6 (60.00) | 29.6817 |
2010's | 4 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ohe, Y | 1 |
Kunimasa, K | 1 |
Watanabe, Y | 1 |
Wehrmann, T | 1 |
Riphaus, A | 1 |
Cohen, LB | 1 |
Horiuchi, A | 1 |
Nakayama, Y | 1 |
Hidaka, N | 1 |
Ichise, Y | 1 |
Kajiyama, M | 1 |
Tanaka, N | 1 |
Cho, JH | 1 |
Kim, JH | 1 |
Lee, YC | 1 |
Song, SY | 1 |
Lee, SK | 1 |
Lee, CK | 1 |
Lee, SH | 2 |
Chung, IK | 1 |
Lee, TH | 1 |
Park, SH | 1 |
Kim, EO | 1 |
Kim, HS | 1 |
Kim, SJ | 1 |
Wani, S | 1 |
Azar, R | 1 |
Hovis, CE | 1 |
Hovis, RM | 1 |
Cote, GA | 1 |
Hall, M | 1 |
Waldbaum, L | 1 |
Kushnir, V | 1 |
Early, D | 1 |
Mullady, DK | 1 |
Murad, F | 1 |
Edmundowicz, SA | 1 |
Jonnalagadda, SS | 1 |
Külling, D | 1 |
Rothenbühler, R | 1 |
Inauen, W | 1 |
Yusoff, IF | 1 |
Raymond, G | 1 |
Sahai, AV | 1 |
Vargo, JJ | 1 |
Zuccaro, G | 1 |
Dumot, JA | 1 |
Shay, SS | 1 |
Conwell, DL | 1 |
Morrow, JB | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
The Value of Integrated Pulmonary Index Monitoring[NCT05356819] | 154 participants (Actual) | Interventional | 2018-10-01 | Completed | |||
Incidence of Sedation Related Complications With Propofol Alone Versus Propofol With Benzodiazepines and Opiates in a High Risk Group Undergoing Advanced Endoscopic Procedures: A Randomized Controlled Trial[NCT01315158] | 36 participants (Actual) | Interventional | 2011-01-31 | Terminated (stopped due to - The research team is not able to obtain the necessary support to continue the study.) | |||
Same Day Bidirectional Endoscopies - Does the Sequence of Procedures or Choice of Insufflator Matter?[NCT02635217] | 200 participants (Actual) | Interventional | 2016-01-31 | Completed | |||
[NCT01491126] | 170 participants (Anticipated) | Observational | 2012-01-31 | Not yet recruiting | |||
Phase 4, Prospective, Randomized, Double-blinded, Placebo-controlled Study Comparing Propofol vs. Midazolam Plus Propofol for Nonanesthesiologist Targeted Moderate Sedation in Outpatient Colonoscopy[NCT01428882] | Phase 4 | 135 participants (Actual) | Interventional | 2011-06-30 | Completed | ||
Use of Non-Invasive Positive Pressure Ventilation in Patients With Severe Obesity Undergoing Upper Endoscopy Procedures[NCT03529461] | 56 participants (Actual) | Interventional | 2017-04-25 | Completed | |||
Safety and Efficacy Evaluation of Remimazolam for Endoscopic Ultrasound-guided Fine Needle Aspiration/Biopsy[NCT05437497] | 264 participants (Anticipated) | Interventional | 2021-08-01 | Recruiting | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
In high risk patients (meeting at least of 1 of 3 criteria: ASA ≥ 3, BMI ≥ 30, those at risk for OSA) undergoing advanced endoscopy procedures, compare the number of participants who experience airway maneuvers (AMs) when sedated with propofol alone versus propofol in combination with benzodiazepines and opioids. (NCT01315158)
Timeframe: One day (during procedure)
Intervention | participants (Number) |
---|---|
Propofol+Benzo/Opioids | 4 |
Propofol Alone | 4 |
Compare the number of participants who experience other sedation related complications such as hypotension, hypoxemia and need for termination of the procedure between the two groups (NCT01315158)
Timeframe: One day (during procedure)
Intervention | participants (Number) |
---|---|
Propofol+Benzo/Opioids | 0 |
Propofol Alone | 0 |
The number of participants who experience symptoms of nausea and vomiting in the two groups of patients will be recorded. This will be recorded during the follow-up phone call made 24-48 hours after the procedure. (NCT01315158)
Timeframe: 24-48 hours
Intervention | participants (Number) |
---|---|
Propofol+Benzo/Opioids | 2 |
Propofol Alone | 1 |
(NCT01315158)
Timeframe: One year
Intervention | incidences (Number) |
---|---|
Propofol+Benzo/Opioids | 0 |
Propofol Alone | 0 |
(NCT01315158)
Timeframe: One year
Intervention | incidences (Number) |
---|---|
Propofol+Benzo/Opioids | 0 |
Propofol Alone | 0 |
(NCT01315158)
Timeframe: One year
Intervention | incidences (Number) |
---|---|
Propofol+Benzo/Opioids | 0 |
Propofol Alone | 0 |
(NCT01315158)
Timeframe: One year
Intervention | participants (Number) |
---|---|
Propofol+Benzo/Opioids | 0 |
Propofol Alone | 0 |
"After completion of the procedure, the patient stood in the examination room monitored continuously by a nurse. When patients responded to normal verbal command, they were asked to sit up and were offered a drink. This was considered the early recovery time.~If they were able to stand unassisted by the bed and had stable hemodynamics parameters (saturation>90 % on room air and blood pressure and heart rate within 20 % of baseline), they were transferred to a locker room accompanied by a relative. The discharge criteria included ability to stand unassisted and tolerate clear liquids once dressed. Once a patient met discharge criteria, they were allowed to leave at their own discretion" (NCT01428882)
Timeframe: Up to 1 hour after colonoscopy
Intervention | minutes (Mean) | |
---|---|---|
Early recovery time | Discharge time | |
Midazolam Balanced Propofol Sedation | 6.8 | 10.4 |
Single-agent Propofol Sedation | 5.3 | 9.80 |
Assessment every two minutes of the level of sedation during the endoscopic procedure, rating it as minimal, moderate or deep. (NCT01428882)
Timeframe: Up to 1 hour after introduction of the colonoscope
Intervention | participants (Number) | |||
---|---|---|---|---|
Deep sedation at any point | Deep sedation at minute 4 | Deep sedation at minute 6 | Deep sedation at minute 8 | |
Midazolam Balanced Propofol Sedation | 22 | 10 | 12 | 10 |
Single-agent Propofol Sedation | 9 | 1 | 2 | 3 |
"Endoscopists and patients rated their satisfaction with sedation in a 10-cm visual analogue scale after discharge.The patients were contacted 24-48 h after the procedure to answer a questionnaire regarding if they remembered scope insertion or scope removal and willingness to repeat it with a similar protocol and rated their satisfaction and pain perception from 0 to 10. This phone survey was done by the nurse specifically making the measurements in the endoscopy room, who was blinded to the sedation regimen.~For the interpretation of results of the 0-10 point numerical scale, 0 stands for 'extremely dissatisfied with sedation level during the endoscopic procedure', whereas 10 stands for 'extremely satisfied with sedation level during the endoscopic procedure." (NCT01428882)
Timeframe: Up to 1 hour after colonoscopy for endoscopists and up to 48 hours for patients
Intervention | units on a scale (Mean) | |
---|---|---|
Endoscopist Satisfaction | Patient Satisfaction | |
Midazolam Balanced Propofol Sedation | 8.9 | 9.8 |
Single-agent Propofol Sedation | 8.4 | 9.5 |
The following events were considered complications of procedural sedation: a decline in oxygen saturation to less than 85 % longer than 30 s after increasing the oxygen flow rate to 5 L/min and transient propofol interruption, a heart rate less than 40 beats per minute and blood pressure less than 80/50 mmHg. Major complications were defined as need for mechanical ventilation or any cardiorespiratory event requiring anaesthesiologist assistance. (NCT01428882)
Timeframe: Up to two hours, including colonoscopy performance and recovery period
Intervention | participants (Number) | ||
---|---|---|---|
Transient oxygen desaturation | Bradycardia | Arterial Hypotension | |
Midazolam Balanced Propofol Sedation | 5 | 2 | 3 |
Single-agent Propofol Sedation | 5 | 1 | 2 |
We used non-invasive positive pressure ventilation (NIPPV) as a first rescue maneuver in control patients who developed an oxygen desaturation less than 90 % and reported on the percentage of participants who responded. The rescue was considered successful with recovery of oxygen saturation more than 90 % within 3 minutes. (NCT03529461)
Timeframe: 3 minutes following a desaturation event < 90 %
Intervention | Participants (Count of Participants) |
---|---|
Control Participants With Oxygen Desaturation < 90% | 8 |
Percentage of participants who develop a peripheral oxygen saturation event < 90%. (NCT03529461)
Timeframe: Time in seconds beginning with the start of procedure (anesthesia induction) ending with procedure completion (eyes open to verbal stimuli).
Intervention | percentage of participants (Number) |
---|---|
Control | 28.6 |
Experimental | 3.5 |
Percentage of participants who develop a peripheral oxygen saturation measured by pulse oximetry ≤ 94% (NCT03529461)
Timeframe: Time in seconds beginning with the start of procedure (anesthesia induction) ending with procedure completion (eyes open to verbal stimuli).
Intervention | percentage of participants (Number) |
---|---|
Control | 57.1 |
Experimental | 14.3 |
3 trials available for propofol and Digestive System Disorders
Article | Year |
---|---|
Low-dose propofol sedation for diagnostic esophagogastroduodenoscopy: results in 10,662 adults.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Anesthesia Recovery Period; Anesthetics, Intravenous; C | 2009 |
Comparison of procedural sequences in same-day bidirectional endoscopy without benzodiazepine and propofol sedation: starting at the bottom or the top.
Topics: Adult; Aged; Anemia; Benzodiazepines; Colonoscopy; Conscious Sedation; Digestive System Diseases; En | 2010 |
Comparison of procedural sequences in same-day bidirectional endoscopy without benzodiazepine and propofol sedation: starting at the bottom or the top.
Topics: Adult; Aged; Anemia; Benzodiazepines; Colonoscopy; Conscious Sedation; Digestive System Diseases; En | 2010 |
Comparison of procedural sequences in same-day bidirectional endoscopy without benzodiazepine and propofol sedation: starting at the bottom or the top.
Topics: Adult; Aged; Anemia; Benzodiazepines; Colonoscopy; Conscious Sedation; Digestive System Diseases; En | 2010 |
Comparison of procedural sequences in same-day bidirectional endoscopy without benzodiazepine and propofol sedation: starting at the bottom or the top.
Topics: Adult; Aged; Anemia; Benzodiazepines; Colonoscopy; Conscious Sedation; Digestive System Diseases; En | 2010 |
Balanced propofol sedation for therapeutic GI endoscopic procedures: a prospective, randomized study.
Topics: Adult; Aged; Aged, 80 and over; Anesthetics, Intravenous; Cholangiopancreatography, Endoscopic Retro | 2011 |
7 other studies available for propofol and Digestive System Disorders
Article | Year |
---|---|
[Effects of amino acid infusion in preventing intraoperative hypothermia: comparison between sevoflurane versus propofol].
Topics: Aged; Aged, 80 and over; Amino Acids; Anesthesia, Epidural; Anesthesia, General; Body Temperature; D | 2014 |
Sedation with propofol for interventional endoscopic procedures: a risk factor analysis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anesthetics, Intravenous; Conscious Sedation; Digestive | 2008 |
Sedation with propofol for interventional endoscopic procedures: a risk factor analysis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anesthetics, Intravenous; Conscious Sedation; Digestive | 2008 |
Sedation with propofol for interventional endoscopic procedures: a risk factor analysis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anesthetics, Intravenous; Conscious Sedation; Digestive | 2008 |
Sedation with propofol for interventional endoscopic procedures: a risk factor analysis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anesthetics, Intravenous; Conscious Sedation; Digestive | 2008 |
Key opinion leader interview. Fospropofol disodium: new perspectives on endoscopic procedures.
Topics: Conscious Sedation; Digestive System Diseases; Endoscopy, Gastrointestinal; Humans; Injections, Intr | 2008 |
Obesity as a risk factor for sedation-related complications during propofol-mediated sedation for advanced endoscopic procedures.
Topics: Aged; Anesthetics, Intravenous; Body Mass Index; Conscious Sedation; Digestive System Diseases; Endo | 2011 |
Safety of nonanesthetist sedation with propofol for outpatient colonoscopy and esophagogastroduodenoscopy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ambulatory Care; Anesthesia, Intravenous; Anesthesiology | 2003 |
Endoscopist administered propofol for upper-GI EUS is safe and effective: a prospective study in 500 patients.
Topics: Adult; Aged; Anesthetics, Intravenous; Digestive System Diseases; Endoscopy, Gastrointestinal; Femal | 2004 |
Endoscopist administered propofol for upper-GI EUS is safe and effective: a prospective study in 500 patients.
Topics: Adult; Aged; Anesthetics, Intravenous; Digestive System Diseases; Endoscopy, Gastrointestinal; Femal | 2004 |
Endoscopist administered propofol for upper-GI EUS is safe and effective: a prospective study in 500 patients.
Topics: Adult; Aged; Anesthetics, Intravenous; Digestive System Diseases; Endoscopy, Gastrointestinal; Femal | 2004 |
Endoscopist administered propofol for upper-GI EUS is safe and effective: a prospective study in 500 patients.
Topics: Adult; Aged; Anesthetics, Intravenous; Digestive System Diseases; Endoscopy, Gastrointestinal; Femal | 2004 |
Gastroenterologist-administered propofol for therapeutic upper endoscopy with graphic assessment of respiratory activity: a case series.
Topics: Adult; Aged; Arousal; Case-Control Studies; Cholangiopancreatography, Endoscopic Retrograde; Conscio | 2000 |